Use of interferon-ß for the therapy of systemic lupus erythematosus

摘要

Disclosed is the use of Interferon for the production of an agent for the prevention and treatment of SLE and improvement of kidney function glomerulonephritis proteinuria splenomegalia encephalomyelitis and collageninduced arthritis for the prevention of leukocyte infiltration and the prevention of IgGdeposits in kidneys Said agent is particularly suitable for the treatment of SLE WHOtype IV